2m 2m 2m 2m 2m 2m 2m
OMNIAB (OABI)
NASDAQ
$2.52-$0.10 (-3.85%)
Price as of Jun 03, 2026 5:16 PM EDT- $391.4MMarket Cap
- 91.24%1-Year Change
- BiotechnologyIndustry
OMNIAB (OABI)
$2.52-$0.10 (-3.85%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 9.8M -29.53% | 13.9M -59.41% | 34.2M -42.17% | 59.1M N/A | |
Cost of Revenue | 303,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 9.5M -31.72% | 13.9M -59.41% | 34.2M -42.17% | 59.1M +11,539.23% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -47.8M -13.35% | -55.1M -2.50% | -56.5M +16.87% | -48.4M N/A | |
Depreciation and Amortization Expense | 21.8M -7.76% | 23.6M +20.96% | 19.5M +6.84% | 18.2M N/A | |
Total Operating Expenses | 87.6M -13.14% | 100.9M -2.60% | 103.6M +20.83% | 85.7M +16,499.15% | |
Operating Profit | -69.0M -7.43% | -74.5M +7.32% | -69.4M +160.50% | -26.6M +5,059.92% | |
Interest Income | 2.7M -14.36% | 3.1M -38.56% | 5.1M +761.16% | 587,000 N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | 0 N/A | |
Interest Income and Expense and Net | 2.7M -14.36% | 3.1M -38.56% | 5.1M +761.16% | 587,000 N/A | |
Total Nonoperating Income and Expense | 2.7M -13.46% | 3.1M -38.86% | 5.1M +761.33% | 587,000 N/A | |
Income before Taxes | -66.3M -7.17% | -71.4M +10.95% | -64.4M +146.97% | -26.1M +4,946.26% | |
Income Taxes | -1.5M -83.85% | -9.4M -31.77% | -13.7M +268.77% | -3.7M N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -64.8M +4.43% | -62.0M +22.55% | -50.6M +126.65% | -22.3M +4,224.59% | |
Net Income from Continuing Operations Applicable to Common | -66.3M -7.17% | -71.4M +10.95% | -64.4M +146.97% | -26.1M +4,946.26% | |
Basic EPS and Net Income | -0.57 -6.56% | -0.61 +19.61% | -0.51 +96.15% | -0.26 +333.33% | |
Diluted EPS and Net Income | -0.57 -6.56% | -0.61 +19.61% | -0.51 +96.15% | -0.26 +333.33% | |
Basic Weighted Average Shares | 113.6M +11.01% | 102.4M +2.69% | 99.7M +16.84% | 85.3M +462.10% | |
Diluted Weighted Average Shares | 113.6M +11.01% | 102.4M +2.69% | 99.7M +16.84% | 85.3M +462.10% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 25.5M -7.52% | 27.6M +68.71% | 16.4M -51.01% | 33.4M +17,476.37% | |
Short-Term Investments | 28.5M -10.48% | 31.8M -54.92% | 70.6M +28.70% | 54.9M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 54.0M -9.10% | 59.4M -31.67% | 87.0M -1.45% | 88.3M +46,362.35% | |
Total Current Assets | 65.3M -4.10% | 68.1M -28.20% | 94.9M -24.05% | 125.0M +13,270.60% | |
Accumulated Depreciation | 19.3M +49.85% | 12.9M +45.35% | 8.9M +71.09% | 5.2M N/A | |
Property and Plant and Equipment and Net | 9.4M -39.14% | 15.5M -15.11% | 18.2M -8.66% | 20.0M N/A | |
Total Long-Term Assets | 912,000 -40.78% | 1.5M -29.52% | 2.2M -38.95% | 3.6M -98.53% | |
Total Assets | 300.9M -7.57% | 325.6M -13.24% | 375.2M -10.92% | 421.2M +77.96% | |
Income Taxes Payable | 785,000 -66.08% | 2.3M -79.62% | 11.4M -54.27% | 24.8M N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 16.3M +7.73% | 15.1M -34.73% | 23.1M -11.17% | 26.0M +5,838.24% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 78,000 -9.30% | 86,000 +186.67% | 30,000 -34.78% | 46,000 -99.43% | |
Total Liabilities | 33.9M -10.68% | 37.9M -37.43% | 60.6M -24.05% | 79.8M +840.59% | |
Retained Earnings | -166.2M +63.88% | -101.4M +157.58% | -39.4M -449.87% | 11.3M +248.95% | |
Total Stockholders Equity | 267.0M -7.16% | 287.6M -8.57% | 314.6M -7.85% | 341.4M +4,619.28% | |
Total Shares Outstanding | 144.3M +18.68% | 121.6M +4.06% | 116.9M +1.42% | 115.2M +300.76% | |
Cash Flow | |||||
Cash from Operating Activities | -36.5M -8.09% | -39.7M -1,789.99% | 2.3M +165.43% | -3.6M +215.50% | |
Capital Expenditures | 565,000 -69.87% | 1.9M +14.05% | 1.6M -90.42% | 17.2M N/A | |
Cash from Investing Activities | 6.5M -82.93% | 37.9M +306.16% | -18.4M -74.93% | -73.3M -68.90% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 27.9M +114.39% | 13.0M +1,559.64% | -892,000 -100.81% | 110.7M -53.29% | |
Financials Ratio | |||||
Gross Margin | 96.90% N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -705.85% +31.37% | -537.30% +164.43% | -203.19% +350.47% | -45.11% N/A | |
Return on Assets | -20.68% +16.81% | -17.70% +39.28% | -12.71% +87.22% | -6.79% N/A | |
Return on Equity | -23.36% +13.38% | -20.60% +33.49% | -15.43% +15.34% | -13.38% N/A | |
Revenue Growth | -29.53% -50.29% | -59.41% +40.89% | -42.17% N/A | N/A N/A | |
Current Ratio | 4.02 -10.98% | 4.52 +10.00% | 4.11 -14.50% | 4.80 N/A | |
Cash Ratio | 1.57 -14.15% | 1.83 +158.49% | 0.71 -44.85% | 1.28 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow